The mesenchymal stromal cells with the insulin-secreting property isolated from the adipose tissue conjointly with the hematopoietic stem cells extracted from bone marrow, co-infused into the thymic portal circulation and subcutaneous tissue were found to regulate the hyperglycemia in TIDM patients [61]. The gene discussed is INS; the disease is Hyperglycemia.